196 related articles for article (PubMed ID: 22893258)
1. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement.
Ross IL; Levitt NS; Van der Walt JS; Schatz DA; Johannsson G; Haarburger DH; Pillay TS
Horm Metab Res; 2013 Jan; 45(1):62-8. PubMed ID: 22893258
[TBL] [Abstract][Full Text] [Related]
2. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison's Disease.
Ross IL; Lacerda M; Pillay TS; Blom DJ; Johannsson G; Dave JA; Levitt NS; Haarburger D; van der Walt JS
Horm Metab Res; 2016 Dec; 48(12):814-821. PubMed ID: 27813051
[TBL] [Abstract][Full Text] [Related]
3. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
Fichna M; Gryczyńska M; Sowińska A; Sowiński J
Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
[TBL] [Abstract][Full Text] [Related]
4. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
Smans L; Lentjes E; Hermus A; Zelissen P
Hormones (Athens); 2013; 12(1):93-100. PubMed ID: 23624135
[TBL] [Abstract][Full Text] [Related]
5. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
[TBL] [Abstract][Full Text] [Related]
6. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.
Restituto P; Galofré JC; Gil MJ; Mugueta C; Santos S; Monreal JI; Varo N
Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810
[TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
Gagliardi L; Nenke MA; Thynne TR; von der Borch J; Rankin WA; Henley DE; Sorbello J; Inder WJ; Torpy DJ
J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
[TBL] [Abstract][Full Text] [Related]
8. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
Løvås K; Thorsen TE; Husebye ES
J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in patients with Addison's disease: effects of different cortisol replacement modes.
Riedel M; Wiese A; Schürmeyer TH; Brabant G
Exp Clin Endocrinol; 1993; 101(2):106-11. PubMed ID: 8405139
[TBL] [Abstract][Full Text] [Related]
10. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
Oksnes M; Björnsdottir S; Isaksson M; Methlie P; Carlsen S; Nilsen RM; Broman JE; Triebner K; Kämpe O; Hulting AL; Bensing S; Husebye ES; Løvås K
J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
[TBL] [Abstract][Full Text] [Related]
11. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
Björnsdottir S; Øksnes M; Isaksson M; Methlie P; Nilsen RM; Hustad S; Kämpe O; Hulting AL; Husebye ES; Løvås K; Nyström T; Bensing S
Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
[TBL] [Abstract][Full Text] [Related]
12. [Effect of rifampin on the metabolism of glucocorticoids in Addison's disease].
Wang YH; Shi YF; Xiang HD
Zhonghua Nei Ke Za Zhi; 1990 Feb; 29(2):108-11, 127. PubMed ID: 2209230
[TBL] [Abstract][Full Text] [Related]
13. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.
Giordano R; Guaraldi F; Marinazzo E; Fumarola F; Rampino A; Berardelli R; Karamouzis I; Lucchiari M; Manetta T; Mengozzi G; Arvat E; Ghigo E
Endocrine; 2016 Feb; 51(2):360-8. PubMed ID: 26184416
[TBL] [Abstract][Full Text] [Related]
14. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
Agha A; Liew A; Finucane F; Baker L; O'Kelly P; Tormey W; Thompson CJ
Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
[TBL] [Abstract][Full Text] [Related]
15. Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease.
Methlie P; Husebye EE; Hustad S; Lien EA; Løvås K
Eur J Endocrinol; 2011 Nov; 165(5):761-9. PubMed ID: 21896619
[TBL] [Abstract][Full Text] [Related]
16. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
[TBL] [Abstract][Full Text] [Related]
17. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
[TBL] [Abstract][Full Text] [Related]
18. Impact of exogenous glucocorticoid use on salivary cortisol measurements among adults with asthma and rhinitis.
Masharani U; Shiboski S; Eisner MD; Katz PP; Janson SL; Granger DA; Blanc PD
Psychoneuroendocrinology; 2005 Sep; 30(8):744-52. PubMed ID: 15919580
[TBL] [Abstract][Full Text] [Related]
19. Continuous subcutaneous hydrocortisone infusion in Addison's disease.
Løvås K; Husebye ES
Eur J Endocrinol; 2007 Jul; 157(1):109-12. PubMed ID: 17609409
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous hydrocortisone administration for emergency use in adrenal insufficiency.
Hahner S; Burger-Stritt S; Allolio B
Eur J Endocrinol; 2013 Aug; 169(2):147-54. PubMed ID: 23672956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
